Novel biomarkers for risk stratification of Barrett’s oesophagus associated neoplastic progression–epithelial HMGB1 expression and stromal lymphocytic phenotype
Ross J Porter(Queen Elizabeth University Hospital), Mairi H McLean(University of Dundee)
Cited by 19